Multicenter, randomized, double-blind, parallel group, placebo-controlled study of the analgesic efficacy of XP20B [dextropropoxyphene-napsilate/paracetamol] in subjects with pain following bunionectomy surgery

Trial Profile

Multicenter, randomized, double-blind, parallel group, placebo-controlled study of the analgesic efficacy of XP20B [dextropropoxyphene-napsilate/paracetamol] in subjects with pain following bunionectomy surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Oct 2008

At a glance

  • Drugs Dextropropoxyphene/paracetamol (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Xanodyne Pharmaceuticals
  • Most Recent Events

    • 07 Oct 2008 Actual end date (August 2008) added as reported by CT.gov
    • 07 Oct 2008 Status changed from recruiting to completed as reported by CT.gov
    • 01 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top